Cbdmd, INC S-1 registration statements

cbdMD, Inc. registers up to 2,000,000 common shares for resale by selling shareholders, stemming from recent Series C Preferred Stock conversions, with no new proceeds for the company.

cbdMD, Inc. has entered into a $20 million equity line of credit agreement with C/M Capital Master Fund, LP to bolster working capital and general corporate purposes, while navigating significant dilution risks.

cbdMD, Inc. filed an S-1/A to register 1.7 million common shares for resale by Series B Preferred Stock holders, while detailing recent capital raises, reduced operating losses, and significant regulatory challenges.

cbdMD, Inc. filed an S-1 registration statement for the resale of 1.7 million common shares by selling shareholders who acquired Series B Convertible Preferred Stock.

cbdMD, Inc. has filed a registration statement for the potential resale of up to 5,138,890 shares of its common stock by selling shareholders, stemming from a recent private placement involving convertible notes.

cbdMD, Inc. has filed a registration statement for the potential resale of up to 5,138,890 shares of its common stock by selling shareholders, following a recent private placement involving convertible notes.